Want to track 0QOI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Newron Pharmaceuticals SpA (0QOI) Statistics
Valuation metrics
Market Cap -
Enterprise value 298.22M
Trailing P/E (ttm) -19.7
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) 14.23
Price/Book (mrq) -23.48
Enterprise Value/Revenue 15.58
Enterprise Value/EBITDA -65.76
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.44K
Average volume (90 days) 16.68K
Price summary
52-Week low 6.62
52-Week high 31.85
Beta -
50-Day moving average 13.69
200-Day moving average 18.04
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.69%
Operating margin -0.25%
Operational effectiveness
Return on assets -0.33%
Return on equity 2.78%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.96
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.66
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.45
Total debt (mrq) -
Total Debt/Equity (mrq) -3.43
Current ratio (mrq) 0.76%
Book value per share (mrq) -0.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
